Role of microenvironment on the fate of disseminating cancer stem cells

Vincenzo Ingangi, Michele Minopoli, Concetta Ragone, Maria Letizia Motti, Maria Vincenza Carriero

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling pathways that support their survival, self-renewal dormancy and reactivation. In the metastatic niche, tumor cells may enter in a dormant state to survive and, consequently, the metastasis can remain latent for years. Despite the clinical importance of metastatic latency, little is known about what induces CSCs to enter a dormant state and what allows them to remain viable for years in this state. CSCs exhibit genetic, epigenetic and cellular adaptations that confer resistance to classical therapeutic approaches. The identification of potential CSC targets is complicated by the fact that CSCs may arise as a consequence of their relationship with the local microenvironment into the metastatic niches. Indeed, microenvironment modulates the capability of CSCs to evade the innate immune response and survive. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of CSCs in tumors and/or overcoming their resistance in preclinical studies. This review will focus on specific CSC features with an emphasis on the role of tumor microenvironment in supporting metastatic dissemination of CSCs. In addition, it sheds light on potential microenvironment-targeted therapies aimed to counteract seeding and survival of CSCs in the metastatic niche.

Original languageEnglish
Article number82
JournalFrontiers in Oncology
Volume9
Issue numberFEB
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Neoplastic Stem Cells
Tumor Microenvironment
Drug Delivery Systems
Innate Immunity
Epigenomics
Neoplasms
Therapeutics
Neoplasm Metastasis

Keywords

  • Agents targeting microenvironment
  • Cancer stem cells
  • Dormancy
  • Metastatic niche
  • Microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Role of microenvironment on the fate of disseminating cancer stem cells. / Ingangi, Vincenzo; Minopoli, Michele; Ragone, Concetta; Motti, Maria Letizia; Carriero, Maria Vincenza.

In: Frontiers in Oncology, Vol. 9, No. FEB, 82, 01.01.2019.

Research output: Contribution to journalReview article

Ingangi, Vincenzo ; Minopoli, Michele ; Ragone, Concetta ; Motti, Maria Letizia ; Carriero, Maria Vincenza. / Role of microenvironment on the fate of disseminating cancer stem cells. In: Frontiers in Oncology. 2019 ; Vol. 9, No. FEB.
@article{02978112f1fe46219fa1115e0177afa4,
title = "Role of microenvironment on the fate of disseminating cancer stem cells",
abstract = "Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling pathways that support their survival, self-renewal dormancy and reactivation. In the metastatic niche, tumor cells may enter in a dormant state to survive and, consequently, the metastasis can remain latent for years. Despite the clinical importance of metastatic latency, little is known about what induces CSCs to enter a dormant state and what allows them to remain viable for years in this state. CSCs exhibit genetic, epigenetic and cellular adaptations that confer resistance to classical therapeutic approaches. The identification of potential CSC targets is complicated by the fact that CSCs may arise as a consequence of their relationship with the local microenvironment into the metastatic niches. Indeed, microenvironment modulates the capability of CSCs to evade the innate immune response and survive. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of CSCs in tumors and/or overcoming their resistance in preclinical studies. This review will focus on specific CSC features with an emphasis on the role of tumor microenvironment in supporting metastatic dissemination of CSCs. In addition, it sheds light on potential microenvironment-targeted therapies aimed to counteract seeding and survival of CSCs in the metastatic niche.",
keywords = "Agents targeting microenvironment, Cancer stem cells, Dormancy, Metastatic niche, Microenvironment",
author = "Vincenzo Ingangi and Michele Minopoli and Concetta Ragone and Motti, {Maria Letizia} and Carriero, {Maria Vincenza}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fonc.2019.00082",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Role of microenvironment on the fate of disseminating cancer stem cells

AU - Ingangi, Vincenzo

AU - Minopoli, Michele

AU - Ragone, Concetta

AU - Motti, Maria Letizia

AU - Carriero, Maria Vincenza

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling pathways that support their survival, self-renewal dormancy and reactivation. In the metastatic niche, tumor cells may enter in a dormant state to survive and, consequently, the metastasis can remain latent for years. Despite the clinical importance of metastatic latency, little is known about what induces CSCs to enter a dormant state and what allows them to remain viable for years in this state. CSCs exhibit genetic, epigenetic and cellular adaptations that confer resistance to classical therapeutic approaches. The identification of potential CSC targets is complicated by the fact that CSCs may arise as a consequence of their relationship with the local microenvironment into the metastatic niches. Indeed, microenvironment modulates the capability of CSCs to evade the innate immune response and survive. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of CSCs in tumors and/or overcoming their resistance in preclinical studies. This review will focus on specific CSC features with an emphasis on the role of tumor microenvironment in supporting metastatic dissemination of CSCs. In addition, it sheds light on potential microenvironment-targeted therapies aimed to counteract seeding and survival of CSCs in the metastatic niche.

AB - Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling pathways that support their survival, self-renewal dormancy and reactivation. In the metastatic niche, tumor cells may enter in a dormant state to survive and, consequently, the metastasis can remain latent for years. Despite the clinical importance of metastatic latency, little is known about what induces CSCs to enter a dormant state and what allows them to remain viable for years in this state. CSCs exhibit genetic, epigenetic and cellular adaptations that confer resistance to classical therapeutic approaches. The identification of potential CSC targets is complicated by the fact that CSCs may arise as a consequence of their relationship with the local microenvironment into the metastatic niches. Indeed, microenvironment modulates the capability of CSCs to evade the innate immune response and survive. Some new therapeutic options that include drugs targeting microenvironment components are achieving encouraging results in reducing the number of CSCs in tumors and/or overcoming their resistance in preclinical studies. This review will focus on specific CSC features with an emphasis on the role of tumor microenvironment in supporting metastatic dissemination of CSCs. In addition, it sheds light on potential microenvironment-targeted therapies aimed to counteract seeding and survival of CSCs in the metastatic niche.

KW - Agents targeting microenvironment

KW - Cancer stem cells

KW - Dormancy

KW - Metastatic niche

KW - Microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85063273406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063273406&partnerID=8YFLogxK

U2 - 10.3389/fonc.2019.00082

DO - 10.3389/fonc.2019.00082

M3 - Review article

AN - SCOPUS:85063273406

VL - 9

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - FEB

M1 - 82

ER -